• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Integrator: A guardian of the human transcriptome

Bioengineer by Bioengineer
January 5, 2021
in Biology
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Søren Lykkke-Andersen

In a joint collaboration, Danish and German researchers have characterized a cellular activity that protects our cells from potentially toxic by-products of gene expression. This activity is central for the ability of multicellular organisms to uphold a robust evolutionary ‘reservoir’ of gene products.

Manufacturing processes need quality control systems in order to ensure proper assembly of functional products. Moreover, space-consuming, and perhaps even toxic, by-products of such processes need to be properly discarded or recycled by efficient waste handling systems.

By analogy, transcription of our genome is an imperfect process that produces large quantities of non-functional and potentially harmful transcripts both from within and outside of conventional genes. The RNA polymerase II enzyme transcribes the majority of our genes, and it also generates pervasive transcripts from multiple non-genic regions. Over the past decade, it has become increasingly clear that the enzyme is relatively promiscuous when it comes to where it starts, and there are transcription initiation sites scattered everywhere in the genome. However, not all these sites are associated with a ‘proper’ gene, and this requires the presence of specific gene-defining elements.

Discovery of new activity of the protein complex ‘Integrator’

In a new article published in the international journal Molecular Cell, a Danish-German research team has now demonstrated that the multi-protein complex ‘Integrator’ – which was previously described as the transcription termination factor for a specific class of genes encoding small nuclear (sn)RNAs – is in fact a default ‘early’ termination factor for most, if not all RNA polymerase II initiation events (Figure, top panel).

The resulting short transcripts are in most cases rapidly degraded by the ribonucleolytic RNA exosome. This mechanism is also at play to varying degrees inside conventional genes, but these have evolved elements, counteracting such early termination, to facilitate productive transcription elongation, which eventually produces functional transcripts such as protein-coding ‘messenger’ (m)RNA (Figure, bottom panel).

Through this newly discovered mechanism of action, Integrator ensures that production of wasteful transcripts remains limited, while at the same time allowing maintenance of thousands of transcription start sites under neutral selection in the human genome. These provide a reservoir of transcription units that may turn into functional genes over time, exemplified by the evolution of the currently known functional RNAs of our genome. As a curious example, snRNA genes appear to be a special case, taking advantage of the general early termination activity of Integrator and fend off the ensuing RNA exosome activity to allow production of stable functional RNAs (Figure, top panel).

Inactivating mutations in Integrator subunits lead to severe neurodevelopmental disorders, and elevated expression of some integrator subunits is associated with increased epithelial-to-mesenchymal transition – a key step in tumor metastasis. This duality highlights the need for a tight control of the Integrator activity. Moreover, the realization that Integrator is a general attenuator of nonproductive transcription may inform the molecular characterization and potential treatment of such ailments.

###

The work was carried out in a collaboration between researchers from Max Planck Institute in Göttingen and Aarhus University.

The scientific article was published in the international journal Molecular Cell:

Søren Lykke-Andersen, Kristina ?umer, Ewa Šmidová Molska, Jérôme O. Rouvière, Guifen Wu, Carina Demel, Björn Schwalb, Manfred Schmid, Patrick Cramer and Torben Heick Jensen

“Integrator is a genome-wide attenuator of nonproductive transcription”

DOI: https://doi.org/10.1016/j.molcel.2020.12.014

For further information, please contact

Søren Lykke-Andersen, PhD – sla@mbg.au.dk – mobile: +45 50510996

Professor Torben Heick Jensen – thj@mbg.au.dk – mobile: +45 60202705

Department of Molecular Biology and Genetics, Aarhus University, Denmark

Media Contact
Professor Torben Heick Jensen
thj@mbg.au.dk

Original Source

https://mbg.au.dk/en/news-and-events/news-item/artikel/integrator-a-guardian-of-the-human-transcriptome/

Related Journal Article

http://dx.doi.org/10.1016/j.molcel.2020.12.014

Tags: BiochemistryBiologyBiotechnologyCell BiologyGeneticsMicrobiologyMolecular Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

Vet-OncoNet Framework Harmonises Fifty-Eight Thousand Animal Tumour Records Across Seven Laboratories

Vet-OncoNet Framework Harmonises Fifty-Eight Thousand Animal Tumour Records Across Seven Laboratories

November 18, 2026
Camelid-Derived Ubiquibodies Enable Targeted Clearance of Pathogenic CRX Protein Variants

Camelid-Derived Ubiquibodies Enable Targeted Clearance of Pathogenic CRX Protein Variants

November 18, 2026

Blood Flow-Restricted Resistance Training Alleviates Cardiovascular Damage in Hypertensive Rats

November 18, 2026

Pancreatic Disorders Share Metabolic Nexus Regulating Calcium Pump Fuelling and Survival

November 18, 2026
Please login to join discussion

POPULAR NEWS

  • Elite Luge Athletes Experience Seasonal Shifts in Body Composition and Biomarkers

    Elite Luge Athletes Experience Seasonal Shifts in Body Composition and Biomarkers

    29 shares
    Share 12 Tweet 7
  • Olive Oil Supplementation Remodels Plasma Lipids and Metabolites in Aged Tauopathy Mice

    29 shares
    Share 12 Tweet 7
  • Mitophagy Inhibitor Ac220 Enhances Magnolol Antitumor Action in Ewing Sarcoma

    29 shares
    Share 12 Tweet 7
  • Systematic Review Finds Long-Term Data Scarce for Chronic Neuropathic Pain Treatments

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Desflurane Shortens Postoperative Recovery Times Compared to Sevoflurane in Elderly Patients

Pestivirus Scrofae Crosses Blood-Testis Barrier in Persistently Infected Mature Boar

Machine Learning Model Predicts High-Risk Immune Status in Lung Cancer Patients

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.